CSL LimitedASX: CSL

2016 FY Results Announcements and Analysts Briefing

· Issued by CSL Limited

Filed with ASX · · 42 pages · English

CSL Limited (ASX:CSL; USOTC:CSLLY) today announced a net profit after tax (NPAT) of US$1,242 million for the full year ended 30 June 2016. After excluding the financials relating to the Novartis influenza vaccines business acquired during the year, underlying1 NPAT grew 5% and earnings per share (EPS) grew 7% on a constant currency (CC)2 basis. HIGHLIGHTS Financial • Revenue US$6,129 million o Und

CSL Limited on 6ix

Earlier from CSL

Later from CSL

All CSL news releases